Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
regulatory(beta) subunit of casein kinase II\; plays a role as a docking site for a subset of CK2 substrates [RGD, Feb 2006].. Additionally we are shipping Casein Kinase 2, alpha Prime Polypeptide Proteins (11) and Casein Kinase 2, alpha Prime Polypeptide Kits (8) and many more products for this protein.
Showing 10 out of 64 products:
Human Monoclonal CSNK2A2 Primary Antibody for FACS, ELISA - ABIN1098114
Chemnitz, Pieper, Grüttner, Hauber: Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression. in European journal of immunology 2009
Show all 2 Pubmed References
this study shows that breakpoint cluster region protein (show BCR Antibodies) regulates inflammation development via the alpha subunit of casein kinase II (show CSNK2A1 Antibodies)
we identify a therapeutically exploitable posttranslational mechanism by which CK2alpha-mediated degradation of BRMS1 (show BRMS1 Antibodies) promotes metastases in lung cancer
These data support a role for casein kinase 2 in regulation of protein synthesis by downregulating stress granule formation through G3BP1 (show G3BP1 Antibodies).
In this study, the disordered feature of Nopp140 (show NOLC1 Antibodies) and the effect of CK2alpha on the structure of Nopp140 (show NOLC1 Antibodies) were examined using single-molecule fluorescence resonance energy transfer (smFRET) and electron paramagnetic resonance (EPR (show EREG Antibodies)).
KLF4 (show KLF4 Antibodies) acts as a tumor suppressor or oncogene (show RAB1A Antibodies) to activate or repress target gene transcription depending on its acetylation status, which is regulated by p21 (show CDKN1A Antibodies) and CK2 (show CSNK2A1 Antibodies) interaction-mediated HDAC2 (show HDAC2 Antibodies) phosphorylation
CK2 (show CSNK2A1 Antibodies) is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and may have role in malignant B-cell growth.
We conclude that this class of chimeric peptides, in addition to altering some properties of CK2 (show CSNK2A1 Antibodies) holoenzyme, affects several other cellular targets, causing profound perturbations of cell biology
Over-expressed CK2alpha positively regulate Hh/Gli1 (show GLI1 Antibodies) signaling in human mesothelioma.
we propose that Foxc2 (show FOXC2 Antibodies) is functionally maintained in the cytoplasm of normal epithelial cells by CK2alpha/alpha'-mediated phosphorylation at serine 124, which is dependent on proper targeting of the holoenzyme via the CK2b (show CSNK2B Antibodies) regulatory subunit.
Data suggest casein kinase II (show CSNK2A1 Antibodies) (CK2 (show CSNK2A1 Antibodies)) inhibitors indeno[1,2-b]indole-9,10-dione, which also inhibited the breast cancer resistance protein ABCG2, might be a good therapeutic strategy to improve anticancer drug efficiency.
Data (including data from studies using knockout mice) suggest that Brg1 (show SMARCA4 Antibodies) is phosphorylated by casein kinase 2 (Ck2 (show CSNK2A1 Antibodies); Ck2alpha1 and Ck2alpha-prime are catalytic subunits) in proliferating skeletal myoblasts; Brg1 (show SMARCA4 Antibodies) is catalytic subunit of SWI (show SMARCA1 Antibodies)/SNF (show SNRPA Antibodies) chromatin-remodeling enzymes; Ck2 (show CSNK2A1 Antibodies)-mediated phosphorylation of Brg1 (show SMARCA4 Antibodies) appears to regulate myoblast proliferation. (Brg1 (show SMARCA4 Antibodies) = Brahma (show SMARCA2 Antibodies)-related gene 1 protein)
data implicate CK2 (show CSNK2A1 Antibodies) as a regulator of the Th17/Treg axis and Th17 cell maturation and suggest that CK2 (show CSNK2A1 Antibodies) could be targeted for the treatment of Th17 cell-driven autoimmune disorders.
CD5-CK2 signaling axis regulates positive selection by modulating activation of ERK and promoting survival independent of proximal TCR signals
This study shows for the first time that LPS (show TLR4 Antibodies) inhibits colonic biotin uptake via decreasing membrane expression of its transporter and that these effects likely involve a CK2 (show CSNK2A1 Antibodies)-mediated pathway.
CK2.1 peptide drives chondrogenesis and cartilage formation without induction of chondrocyte hypertrophy by releasing CK2 (show CSNK2A1 Antibodies) from distinct sites at BMPRIa (show BMPR1A Antibodies)
showed that inhibition of CK2 (show CSNK2A1 Antibodies) greatly enhanced M3R (show CHRM3 Antibodies)-stimulated insulin (show INS Antibodies) secretion in human islets
CK2 (show CSNK2A1 Antibodies)-regulated IQJC-SCHIP-1 association with AnkG (show ANK3 Antibodies) contributes to axon initial segment maintenance.
We suggest that L1 stimulates neuritogenesis by activating CK2alpha leading to decreased levels of PTEN and p53 (show TP53 Antibodies) via a novel, L1-triggered and CK2alpha-mediated signal transduction pathway.
our results identify CK2 (show CSNK2A1 Antibodies) as a novel regulator of TBK1 (show TBK1 Antibodies) and IRF3 (show IRF3 Antibodies) and suggest that targeting CK2 (show CSNK2A1 Antibodies) by small molecular inhibitor may be a viable approach to prevent and treat viral infections.
Cytokine-induced activation of NFkappaB in beta cells is dependent on CK2 (show CSNK2A1 Antibodies) activity, which phosphorylates NFkappaB p65 (show NFkBP65 Antibodies) at serine 529.
regulatory(beta) subunit of casein kinase II\; plays a role as a docking site for a subset of CK2 substrates
CK II alpha'
, casein kinase II subunit alpha'
, casein kinase II, alpha 2, polypeptide
, casein kinase 2, alpha prime polypeptide
, casein kinase II subunit alpha'-like
, casein kinase 2 alpha 2
, ck2 alpha'
, CK II
, casein kinase II, alpha' subunit
, LOW QUALITY PROTEIN: casein kinase II subunit alpha'